{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:18:41Z","timestamp":1773004721233,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cong Wang","award":["CSTB2022NSCQMSX1008"],"award-info":[{"award-number":["CSTB2022NSCQMSX1008"]}]},{"name":"Lili Zhang","award":["cstc2018jcyjAXO210"],"award-info":[{"award-number":["cstc2018jcyjAXO210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metabolic dysfunction associated with fatty liver disease (MAFLD) is often correlated with obesity and hyperuricemia. The present study aimed to determine the association between serum uric acid (SUA) and central fat distribution in patients with MAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 485 patients were classified into the following groups: (1) controls without MAFLD and hyperuricemia (HUA), (2) MAFLD with normal SUA, and (3) MAFLD with HUA. DUALSCAN HDS-2000 was used to measure visceral fat (VAT) and subcutaneous fat (SAT). Dual-energy X-ray absorptiometry (DEXA) was used to measure body fat distribution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MAFLD patients with HUA had remarkably higher BMI, fasting insulin, OGIRT AUC, ALT, AST, TG, VAT, SAT, Adipo-IR, trunk fat mass, android fat, and total body fat than MAFLD patients with normal SUA (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The increase in VAT, SAT, CAP, Adipo-IR, upper limbs fat mass, trunk fat mass, and android fat, as well as the percentage of MAFLD, were significantly correlated with the increase in SUA. The percentage of MAFLD patients with HUA increased significantly with increasing VAT or SAT, as determined by the Cochran\u2013Armitage trend test (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Furthermore, VAT (OR\u2009=\u20091.01 CI: 1.00, 1.03; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and adipo-IR (OR\u2009=\u20091.09 CI: 1.00, 1.19; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) were associated with circling SUA in MAFLD after adjusting for sex, age, TG, TC, HOMA-IR, and BMI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Abdominal fat promotes the co-existence of HUA and MAFLD, while weight loss, especially, decreasing VAT, is of great importance to decrease SUA levels and manage MAFLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01447-7","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T09:02:41Z","timestamp":1695632561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Correlation between serum uric acid and body fat distribution in patients with MAFLD"],"prefix":"10.1186","volume":"23","author":[{"given":"Min","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"issue":"7","key":"1447_CR1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999-2014.e1991.","journal-title":"Gastroenterology"},{"issue":"2","key":"1447_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3350\/cmh.2021.0067","volume":"27","author":"SH Kang","year":"2021","unstructured":"Kang SH, Cho Y, Jeong SW, Kim SU, Lee JW. From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? Clin Mol Hepatol. 2021;27(2):257\u201369.","journal-title":"Clin Mol Hepatol"},{"key":"1447_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.plipres.2014.02.002","volume":"54","author":"N Sahini","year":"2014","unstructured":"Sahini N, Borlak J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res. 2014;54:86\u2013112.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1447_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1447_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, MD). 2016;64(1):73\u201384.","journal-title":"Hepatology (Baltimore, MD)"},{"key":"1447_CR6","doi-asserted-by":"crossref","unstructured":"Doherty M. New insights into the epidemiology of gout. Rheumatology (Oxford, England). 2009;48 Suppl 2:ii2-ii8.","DOI":"10.1093\/rheumatology\/kep086"},{"issue":"9","key":"1447_CR7","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/dc09-0288","volume":"32","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, Saito A, Sone H. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737\u201342.","journal-title":"Diabetes Care"},{"issue":"10","key":"1447_CR8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjmed.2010.03.027","volume":"123","author":"V Bhole","year":"2010","unstructured":"Bhole V, Choi JW, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med. 2010;123(10):957\u201361.","journal-title":"Am J Med"},{"issue":"2","key":"1447_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc07-1276","volume":"31","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31(2):361\u20132.","journal-title":"Diabetes Care"},{"issue":"7","key":"1447_CR10","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/HJH.0000000000001721","volume":"36","author":"M Bombelli","year":"2018","unstructured":"Bombelli M, Quarti-Trevano F, Tadic M, Facchetti R, Cuspidi C, Mancia G, Grassi G. Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study. J Hypertens. 2018;36(7):1492\u20138.","journal-title":"J Hypertens"},{"issue":"19","key":"1447_CR11","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.106.657627","volume":"115","author":"ES Ford","year":"2007","unstructured":"Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007;115(19):2526\u201332.","journal-title":"Circulation"},{"issue":"3","key":"1447_CR12","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","volume":"290","author":"T Nakagawa","year":"2006","unstructured":"Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290(3):F625-631.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1447_CR13","doi-asserted-by":"crossref","unstructured":"Kuwabara M, Hisatome I, Niwa K, Hara S, Roncal-Jimenez CA, Bjornstad P, Nakagawa T, Andres-Hernando A, Sato Y, Jensen T, et al. Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study. Hypertension. 2018;71(1):78\u201386.","DOI":"10.1161\/HYPERTENSIONAHA.117.10370"},{"issue":"11","key":"1447_CR14","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1373\/clinchem.2009.124891","volume":"55","author":"W Zhang","year":"2009","unstructured":"Zhang W, Sun K, Yang Y, Zhang H, Hu FB, Hui R. Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis. Clin Chem. 2009;55(11):2026\u201334.","journal-title":"Clin Chem"},{"issue":"9","key":"1447_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM196609012750902","volume":"275","author":"PJ Cannon","year":"1966","unstructured":"Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966;275(9):457\u201364.","journal-title":"N Engl J Med"},{"issue":"3","key":"1447_CR16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.STR.29.3.635","volume":"29","author":"S Lehto","year":"1998","unstructured":"Lehto S, Niskanen L, R\u00f6nnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998;29(3):635\u20139.","journal-title":"Stroke"},{"issue":"12","key":"1447_CR17","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0002-9149(01)01566-1","volume":"87","author":"KR Tuttle","year":"2001","unstructured":"Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001;87(12):1411\u20134.","journal-title":"Am J Cardiol"},{"issue":"5","key":"1447_CR18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/13685538.2020.1713742","volume":"23","author":"M \u0130nanir","year":"2020","unstructured":"\u0130nanir M. Serum uric acid (SUA) in morbidly obese patients and its relationship with metabolic syndrome. Aging Male. 2020;23(5):1165\u20139.","journal-title":"Aging Male"},{"issue":"17","key":"1447_CR19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2169\/internalmedicine.46.0045","volume":"46","author":"M Hikita","year":"2007","unstructured":"Hikita M, Ohno I, Mori Y, Ichida K, Yokose T, Hosoya T. Relationship between hyperuricemia and body fat distribution. Intern Med. 2007;46(17):1353\u20138.","journal-title":"Intern Med"},{"key":"1447_CR20","volume":"12","author":"Z Ran","year":"2021","unstructured":"Ran Z, Xue X, Han L, Terkeltaub R, Merriman TR, Zhao T, He Y, Wang C, Li X, Liu Z, et al. Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients. Front Endocrinol. 2021;12: 724822.","journal-title":"Front Endocrinol"},{"issue":"4","key":"1447_CR21","volume":"8","author":"XY Hu","year":"2018","unstructured":"Hu XY, Li Y, Li LQ, Zheng Y, Lv JH, Huang SC, Zhang W, Liu L, Zhao L, Liu Z, et al. Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. BMJ Open. 2018;8(4): e019974.","journal-title":"BMJ Open"},{"issue":"6","key":"1447_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clinbiochem.2014.01.029","volume":"47","author":"E Sertoglu","year":"2014","unstructured":"Sertoglu E, Ercin CN, Celebi G, Gurel H, Kayadibi H, Genc H, Kara M, Dogru T. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem. 2014;47(6):383\u20138.","journal-title":"Clin Biochem"},{"issue":"3","key":"1447_CR23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.metabol.2012.08.013","volume":"62","author":"JC Sirota","year":"2013","unstructured":"Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism. 2013;62(3):392\u20139.","journal-title":"Metabolism"},{"issue":"4","key":"1447_CR24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/acr.22729","volume":"68","author":"A Yamada","year":"2016","unstructured":"Yamada A, Sato KK, Kinuhata S, Uehara S, Endo G, Hikita Y, Fujimoto WY, Boyko EJ, Hayashi T. Association of Visceral Fat and Liver Fat With Hyperuricemia. Arthritis Care Res. 2016;68(4):553\u201361.","journal-title":"Arthritis Care Res"},{"issue":"7\u20138","key":"1447_CR25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.clinbiochem.2015.12.010","volume":"49","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Wei F, Fan Y. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Biochem. 2016;49(7\u20138):636\u201342.","journal-title":"Clin Biochem"},{"key":"1447_CR26","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Cai M, Dilimulati D, Lin Z, Sun H, Cui R, Fei H, Gao X, Zeng Q, Shao X, et al. Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2021;12: 782808.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"1447_CR27","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s10067-022-06139-6","volume":"41","author":"Y Guo","year":"2022","unstructured":"Guo Y, Huang H, Chen Y, Shen C, Xu C. Association between circulating cystatin C and hyperuricemia: a cross-sectional study. Clin Rheumatol. 2022;41(7):2143\u201351.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1447_CR28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"1447_CR29","first-page":"236","volume":"34","author":"C Wang","year":"2021","unstructured":"Wang C, Peng JJ, Miao H, Liu DF, Zhang LL. Decreased Plasma MANF Levels are Associated with Type 2 Diabetes. Biomed Environ Sci. 2021;34(3):236\u201340.","journal-title":"Biomed Environ Sci"},{"key":"1447_CR30","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/362147","volume":"2012","author":"RD Zheng","year":"2012","unstructured":"Zheng RD, Chen ZR, Chen JN, Lu YH, Chen J. Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease. Gastroenterol Res Pract. 2012;2012: 362147.","journal-title":"Gastroenterol Res Pract"},{"issue":"11","key":"1447_CR31","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825\u201335.","journal-title":"Ultrasound Med Biol"},{"key":"1447_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154837","volume":"125","author":"C Wang","year":"2020","unstructured":"Wang C, He M, Peng J, Li S, Long M, Chen W, Liu D, Yang G, Zhang L. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Cytokine. 2020;125: 154837.","journal-title":"Cytokine"},{"key":"1447_CR33","doi-asserted-by":"crossref","unstructured":"Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Cadarso-Suarez C, Garc\u00eda F, De Francisco A. Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res Clin Pract. 2011;94(1):146\u2013155.","DOI":"10.1016\/j.diabres.2011.07.015"},{"issue":"4","key":"1447_CR34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/hep.23116","volume":"50","author":"A Gastaldelli","year":"2009","unstructured":"Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, MD). 2009;50(4):1087\u201393.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"4","key":"1447_CR35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (Baltimore, MD). 2007;45(4):846\u201354.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"10","key":"1447_CR36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"1447_CR37","first-page":"E350","volume":"21","author":"M Ida","year":"2013","unstructured":"Ida M, Hirata M, Odori S, Mori E, Kondo E, Fujikura J, Kusakabe T, Ebihara K, Hosoda K, Nakao K. Early changes of abdominal adiposity detected with weekly dual bioelectrical impedance analysis during calorie restriction. Obesity (Silver Spring, Md). 2013;21(9):E350-353.","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"5","key":"1447_CR38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/cen.14673","volume":"96","author":"L Fern\u00e1ndez-Chirino","year":"2022","unstructured":"Fern\u00e1ndez-Chirino L, Antonio-Villa NE, Ferm\u00edn-Mart\u00ednez CA, M\u00e1rquez-Salinas A, Guerra EC, Vargas-V\u00e1zquez A, Almeda-Vald\u00e9s P, G\u00f3mez-Velasco D, Viveros-Ruiz TL, Rojas R, et al. Elevated serum uric acid is a facilitating mechanism for insulin resistance mediated accumulation of visceral adipose tissue. Clin Endocrinol. 2022;96(5):707\u201318.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1447_CR39","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/db10-0916","volume":"60","author":"W Baldwin","year":"2011","unstructured":"Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ, Sautin YY. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258\u201369.","journal-title":"Diabetes"},{"key":"1447_CR40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fendo.2020.00577","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Ge J, Zha M, Miao JJ, Sun ZL, Yu JY. Effects of Uric Acid-Lowering Treatment on Glycemia: A Systematic Review and Meta-Analysis. Front Endocrinol. 2020;11:577.","journal-title":"Front Endocrinol"},{"key":"1447_CR41","doi-asserted-by":"crossref","unstructured":"Su M, Sun L, Li W, Liu H, Liu Y, Wei Y, Yuan Y, Zheng L, Yin S, Dai C, et al. Metformin alleviates hyperuricaemia-induced serum FFA elevation and insulin resistance by inhibiting adipocyte hypertrophy and reversing suppressed white adipose tissue beiging. Clin Sci (Lond). 2020;134(12):1537\u20131553.","DOI":"10.1042\/CS20200580"},{"issue":"48","key":"1447_CR42","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","volume":"287","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732\u201344.","journal-title":"J Biol Chem"},{"key":"1447_CR43","doi-asserted-by":"crossref","unstructured":"S\u00f8ndergaard E, Espinosa De Ycaza AE, Morgan-Bathke M, Jensen MD. How to Measure Adipose Tissue Insulin Sensitivity. J Clin Endocrinol Metab. 2017;102(4):1193\u20131199.","DOI":"10.1210\/jc.2017-00047"},{"issue":"2","key":"1447_CR44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1194\/jlr.D020321","volume":"53","author":"E Fabbrini","year":"2012","unstructured":"Fabbrini E, Magkos F, Conte C, Mittendorfer B, Patterson BW, Okunade AL, Klein S. Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects. J Lipid Res. 2012;53(2):321\u20134.","journal-title":"J Lipid Res"},{"key":"1447_CR45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13098-019-0418-x","volume":"11","author":"X Cai","year":"2019","unstructured":"Cai X, Xia L, Pan Y, He D, Zhu H, Wei T, He Y. Differential role of insulin resistance and \u03b2-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2019;11:24.","journal-title":"Diabetol Metab Syndr"},{"key":"1447_CR46","doi-asserted-by":"crossref","unstructured":"Ter Horst KW, van Galen KA, Gilijamse PW, Hartstra AV, de Groot PF, van der Valk FM, Ackermans MT, Nieuwdorp M, Romijn JA, Serlie MJ. Methods for quantifying adipose tissue insulin resistance in overweight\/obese humans. Int J Obes (2005). 2017;41(8):1288\u20131294.","DOI":"10.1038\/ijo.2017.110"},{"issue":"8","key":"1447_CR47","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1210\/clinem\/dgab325","volume":"106","author":"X Li","year":"2021","unstructured":"Li X, Liu J, Zhou B, Li Y, Wu Z, Meng H, Wang G. Sex Differences in the Effect of Testosterone on Adipose Tissue Insulin Resistance From Overweight to Obese Adults. J Clin Endocrinol Metab. 2021;106(8):2252\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"1447_CR48","doi-asserted-by":"crossref","unstructured":"Ryd\u00e9n M, Andersson DP, Arner P. Usefulness of surrogate markers to determine insulin action in fat cells. Int J Obes 2005. 2020;44(12):2436\u20132443.","DOI":"10.1038\/s41366-020-0592-9"},{"key":"1447_CR49","volume":"13","author":"H Sun","year":"2022","unstructured":"Sun H, Chang X, Bian N, An Y, Liu J, Leng S, Wang G. Adipose Tissue Insulin Resistance Is Positively Associated With Serum Uric Acid Levels and Hyperuricemia in Northern Chinese Adults. Front Endocrinol. 2022;13: 835154.","journal-title":"Front Endocrinol"},{"issue":"8","key":"1447_CR50","doi-asserted-by":"crossref","first-page":"e2753","DOI":"10.1210\/clinem\/dgaa265","volume":"105","author":"Y Song","year":"2020","unstructured":"Song Y, S\u00f8ndergaard E, Jensen MD. Unique Metabolic Features of Adults Discordant for Indices of Insulin Resistance. J Clin Endocrinol Metab. 2020;105(8):e2753-2763.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1447_CR51","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","volume":"71","author":"C Rosso","year":"2019","unstructured":"Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, M\u00f8ller HJ, et al. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. J Hepatol. 2019;71(5):1012\u201321.","journal-title":"J Hepatol"},{"issue":"1","key":"1447_CR52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780260115","volume":"26","author":"RJ Glynn","year":"1983","unstructured":"Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961\u20131980. Arthritis Rheum. 1983;26(1):87\u201393.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1447_CR53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/met.2009.0084","volume":"8","author":"R Villegas","year":"2010","unstructured":"Villegas R, Xiang YB, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO. Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord. 2010;8(3):263\u201370.","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"1447_CR54","first-page":"255","volume":"10","author":"S Yamashita","year":"1986","unstructured":"Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes. 1986;10(4):255\u201364.","journal-title":"Int J Obes"},{"issue":"12","key":"1447_CR55","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/rheumatology\/keq256","volume":"49","author":"Y Zhu","year":"2010","unstructured":"Zhu Y, Zhang Y, Choi HK. The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatology (Oxford). 2010;49(12):2391\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1447_CR56","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0026-0495(98)90346-8","volume":"47","author":"F Matsuura","year":"1998","unstructured":"Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47(8):929\u201333.","journal-title":"Metabolism"},{"issue":"11","key":"1447_CR57","volume":"7","author":"B Gao","year":"2012","unstructured":"Gao B, Zhou J, Ge J, Zhang Y, Chen F, Lau WB, Wan Y, Zhang N, Xing Y, Wang L, et al. Association of maximum weight with hyperuricemia risk: a retrospective study of 21,414 Chinese people. PLoS ONE. 2012;7(11): e51186.","journal-title":"PLoS ONE"},{"issue":"6","key":"1447_CR58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039321","volume":"7","author":"T Lyngdoh","year":"2012","unstructured":"Lyngdoh T, Vuistiner P, Marques-Vidal P, Rousson V, Waeber G, Vollenweider P, Bochud M. Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach. PLoS ONE. 2012;7(6): e39321.","journal-title":"PLoS ONE"},{"issue":"3","key":"1447_CR59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000355405","volume":"3","author":"K Chaudhary","year":"2013","unstructured":"Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 2013;3(3):208\u201320.","journal-title":"Cardiorenal Med"},{"issue":"12","key":"1447_CR60","volume":"2","author":"G Jia","year":"2019","unstructured":"Jia G, Shu XO, Liu Y, Li HL, Cai H, Gao J, Gao YT, Wen W, Xiang YB, Zheng W. Association of Adult Weight Gain With Major Health Outcomes Among Middle-aged Chinese Persons With Low Body Weight in Early Adulthood. JAMA Netw Open. 2019;2(12): e1917371.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1447_CR61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13075-018-1612-1","volume":"20","author":"PL Evans","year":"2018","unstructured":"Evans PL, Prior JA, Belcher J, Mallen CD, Hay CA, Roddy E. Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies. Arthritis Res Ther. 2018;20(1):136.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1447_CR62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BOR.0b013e3282f4b1ed","volume":"20","author":"JG Puig","year":"2008","unstructured":"Puig JG, Mart\u00ednez MA. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol. 2008;20(2):187\u201391.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"1447_CR63","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1751-7176.2012.00674.x","volume":"14","author":"MA McAdams-DeMarco","year":"2012","unstructured":"McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J. Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich). 2012;14(10):675\u20139.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"1447_CR64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-021-02461-7","volume":"23","author":"L Bai","year":"2021","unstructured":"Bai L, Zhou JB, Zhou T, Newson RB, Cardoso MA. Incident gout and weight change patterns: a retrospective cohort study of US adults. Arthritis Res Ther. 2021;23(1):69.","journal-title":"Arthritis Res Ther"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01447-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:09:35Z","timestamp":1700298575000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01447-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01447-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University (Chongqing, China), approval number 20238. Written informed consent was obtained from all participants in the study. All methods in the current research were performed in accordance with the declaration of Helsinki\u2019s guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}